Publications by authors named "Courtney Erickson"

Claim this Profile
B
Brain MRI changes in children and young adults with B-cell acute lymphoblastic leukemia following chimeric antigen receptor T-cell therapy.
Hyun Gi Kim, Kristen W Yeom, Iryna Vasyliv, Zahra Shokri Varniab, Courtney Erickson

Eur Radiol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of CAR T cell therapy on thymus size in children and young adults with acute lymphoblastic leukemia.
Iryna Vasyliv, Hyun Gi Kim, Courtney Erickson, Christina Baggott, Liora Michal Schultz

Sci Rep· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous and intracranial GD2-CAR T cells for H3K27M diffuse midline gliomas.
Michelle Monje, Jasia Mahdi, Robbie Majzner, Kristen W Yeom, Liora M Schultz, Courtney Erickson

Nature· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Intravenous and intracranial GD2-CAR T cells for H3K27M diffuse midline gliomas.
Michelle Monje, Jasia Mahdi, Robbie Majzner, Kristen W Yeom, Liora M Schultz, Courtney Erickson

Nature· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: sub-clinical extramedullary B-ALL in the setting of relapse following targeted therapy.
Claire Johns, Courtney Erickson, Ashley Jacobs, Jennifer Moon, Christina Baggott

Front Immunol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential intravenous and intracerebroventricular GD2-CAR T-cell therapy for H3K27M-mutated diffuse midline gliomas.
Michelle Monje, Jasia Mahdi, Robbie Majzner, Kristen Yeom, Liora M Schultz, Courtney Erickson

medRxiv· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD22 CAR T cells demonstrate high response rates and safety in pediatric and adult B-ALL: Phase 1b results.
Liora M Schultz, Nikeshan Jeyakumar, Anne Marijn Kramer, Bita Sahaf, Hrishi Srinagesh, Courtney Erickson

Leukemia· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mediport use as an acceptable standard for CAR T cell infusion.
Maya Eylon, Snehit Prabhu, Samuel John, Maxwell J M King, Dhruv Bhatt, Courtney Erickson

Front Immunol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of peripheral blood MRD and 18F-FDG PET in the post-CAR relapse setting: a case study of discordant peripheral blood and bone marrow MRD.
Liora Schultz, Kara Lynn Davis, Ann Walkush, Christina Baggott, Courtney Erickson

J Immunother Cancer· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas.
Robbie G Majzner, Sneha Ramakrishna, Kristen W Yeom, Shabnum Patel, Harshini Chinnasamy, Courtney Erickson

Nature· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of dual positive CD19+/CD3+ T cells in a leukapheresis product undergoing CAR transduction: a case report.
Liora Schultz, Shabnum Patel, Kara Lynn Davis, Sneha Ramakrishna, Bita Sahaf, Courtney Erickson

J Immunother Cancer· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis